Therapeutic Molecule
Molecular size, polarity, charge, solubility, stability and biological sensitivity define the starting constraints.
Technology overview
From Molecule to Delivery System
Successful drug delivery depends on more than selecting a carrier. It requires an integrated understanding of the therapeutic molecule, the barriers it encounters, the formulation it enters and the attributes needed for translation.
Development logic
A connected formulation-development framework
Jinbosen Bio applies composition–structure–performance driven formulation development to examine how formulation composition and nanoscale organisation can influence stability, biological interaction and translational performance.
Delivery Barrier
Enzymes, mucus, epithelial membranes, cellular uptake and intracellular trafficking may limit delivery.
Formulation Design
Lipids, phospholipids, excipients and process strategy are selected and systematically evaluated.
Nanostructure
Particle size, morphology, membrane organisation, surface properties and payload localisation are considered together.
Biological Interaction
Stability in biological environments, barrier interaction, cellular association, uptake and permeability are assessed as relevant.
Translational Performance
Reproducibility, critical quality attributes, process robustness, scalability and storage stability inform development decisions.
Technology platforms
One philosophy applied to different delivery problems
The platforms below are not isolated service lines. Each applies the same barrier-led, composition–structure–performance approach to a different set of therapeutic and translational requirements.
01
Lipid-Based Delivery
Lipid nanoparticles, classical liposomes and phospholipid assemblies for nucleic acids, peptides, proteins and selected poorly soluble molecules.
Explore lipid delivery → 02Extracellular Vesicle Technologies
EV isolation, purification, formulation, stabilisation and characterisation approached with attention to heterogeneity and reproducibility.
Explore EV technologies → 03Oral & Mucosal Delivery
Formulation strategies for macromolecules that must remain stable and interact appropriately with gastrointestinal, mucus and epithelial barriers.
Explore oral delivery →Composition–structure–performance
Formulation attributes are connected
Relatively small changes in composition, molecular organisation or surface properties can influence nanoparticle behaviour. These relationships require systematic evaluation rather than single-attribute optimisation.
01CompositionLipids, excipients and payload
02StructureAssembly and molecular organisation
03Interfacial PropertiesSurface charge and barrier interaction
04Biological InteractionStability, association and transport
05Delivery PerformanceProtection, release and reproducibility
Project collaboration
Start with the molecule and the barrier—not a predetermined carrier.
We can help frame a feasibility question, compare formulation approaches and define the evidence needed before a broader development programme.